| Variables . | RT (n = 37) . | TAVI (n = 37) . | d . | P . |
|---|---|---|---|---|
| Age (years, mean ± SD) | 79 ± 4.5 | 78.8 ± 7.4 | −2.01 | 0.92 |
| Female [patients, n (%)] | 24 (69.9) | 22 (59.5) | 4.45 | 0.81 |
| COPD [patients, n (%)] | 8 (21.6) | 11 (29.7) | 9.08 | 0.59 |
| Hypertension [patients, n (%)] | 32 (86.5) | 31 (83.8) | −6.04 | 1 |
| Diabetes mellitus [patients, n (%)] | 10 (27) | 7 (18.9) | −10.2 | 0.62 |
| NYHA III–IV functional class [patients, n (%)] | 25 (67.6) | 22 (59.5) | 3.63 | 0.58 |
| Ejection fraction (mean ± SD) | 52.6 ± 9.7 | 50.6 ± 7.8 | −9.8 | 0.5 |
| Extracardiac vasculopathy [patients, n (%)] | 11 (29.7) | 9 (24.3) | −9.9 | 0.79 |
| Previous cardiac surgery [patients, n (%)] | 3 (8.1) | 3 (8.1) | 0 | 1 |
| Serum creatinine (mg/dl ± SD) | 1.1 ± 0.5 | 1.2 ± 0.9 | 3.05 | 0.87 |
| Pulmonary hypertension [patients, n (%)] | 10 (27) | 9 (24.3) | −5.01 | 0.3 |
| Logistic EuroSCORE | ||||
| Median, IQR | 14.2 (7.3–19.7) | 14 (11.1–21.5) | −8.72 | <0.0001 |
| Mean ± SD | 16.1 ± 11 | 15.7 ± 8.5 | ||
| Variables . | RT (n = 37) . | TAVI (n = 37) . | d . | P . |
|---|---|---|---|---|
| Age (years, mean ± SD) | 79 ± 4.5 | 78.8 ± 7.4 | −2.01 | 0.92 |
| Female [patients, n (%)] | 24 (69.9) | 22 (59.5) | 4.45 | 0.81 |
| COPD [patients, n (%)] | 8 (21.6) | 11 (29.7) | 9.08 | 0.59 |
| Hypertension [patients, n (%)] | 32 (86.5) | 31 (83.8) | −6.04 | 1 |
| Diabetes mellitus [patients, n (%)] | 10 (27) | 7 (18.9) | −10.2 | 0.62 |
| NYHA III–IV functional class [patients, n (%)] | 25 (67.6) | 22 (59.5) | 3.63 | 0.58 |
| Ejection fraction (mean ± SD) | 52.6 ± 9.7 | 50.6 ± 7.8 | −9.8 | 0.5 |
| Extracardiac vasculopathy [patients, n (%)] | 11 (29.7) | 9 (24.3) | −9.9 | 0.79 |
| Previous cardiac surgery [patients, n (%)] | 3 (8.1) | 3 (8.1) | 0 | 1 |
| Serum creatinine (mg/dl ± SD) | 1.1 ± 0.5 | 1.2 ± 0.9 | 3.05 | 0.87 |
| Pulmonary hypertension [patients, n (%)] | 10 (27) | 9 (24.3) | −5.01 | 0.3 |
| Logistic EuroSCORE | ||||
| Median, IQR | 14.2 (7.3–19.7) | 14 (11.1–21.5) | −8.72 | <0.0001 |
| Mean ± SD | 16.1 ± 11 | 15.7 ± 8.5 | ||
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; IQR: interquartile range; SD: standard deviation; d: standardized differences; TAVI: transcatheter aortic valve implantation; RT: right anterior minithoracomy.
| Variables . | RT (n = 37) . | TAVI (n = 37) . | d . | P . |
|---|---|---|---|---|
| Age (years, mean ± SD) | 79 ± 4.5 | 78.8 ± 7.4 | −2.01 | 0.92 |
| Female [patients, n (%)] | 24 (69.9) | 22 (59.5) | 4.45 | 0.81 |
| COPD [patients, n (%)] | 8 (21.6) | 11 (29.7) | 9.08 | 0.59 |
| Hypertension [patients, n (%)] | 32 (86.5) | 31 (83.8) | −6.04 | 1 |
| Diabetes mellitus [patients, n (%)] | 10 (27) | 7 (18.9) | −10.2 | 0.62 |
| NYHA III–IV functional class [patients, n (%)] | 25 (67.6) | 22 (59.5) | 3.63 | 0.58 |
| Ejection fraction (mean ± SD) | 52.6 ± 9.7 | 50.6 ± 7.8 | −9.8 | 0.5 |
| Extracardiac vasculopathy [patients, n (%)] | 11 (29.7) | 9 (24.3) | −9.9 | 0.79 |
| Previous cardiac surgery [patients, n (%)] | 3 (8.1) | 3 (8.1) | 0 | 1 |
| Serum creatinine (mg/dl ± SD) | 1.1 ± 0.5 | 1.2 ± 0.9 | 3.05 | 0.87 |
| Pulmonary hypertension [patients, n (%)] | 10 (27) | 9 (24.3) | −5.01 | 0.3 |
| Logistic EuroSCORE | ||||
| Median, IQR | 14.2 (7.3–19.7) | 14 (11.1–21.5) | −8.72 | <0.0001 |
| Mean ± SD | 16.1 ± 11 | 15.7 ± 8.5 | ||
| Variables . | RT (n = 37) . | TAVI (n = 37) . | d . | P . |
|---|---|---|---|---|
| Age (years, mean ± SD) | 79 ± 4.5 | 78.8 ± 7.4 | −2.01 | 0.92 |
| Female [patients, n (%)] | 24 (69.9) | 22 (59.5) | 4.45 | 0.81 |
| COPD [patients, n (%)] | 8 (21.6) | 11 (29.7) | 9.08 | 0.59 |
| Hypertension [patients, n (%)] | 32 (86.5) | 31 (83.8) | −6.04 | 1 |
| Diabetes mellitus [patients, n (%)] | 10 (27) | 7 (18.9) | −10.2 | 0.62 |
| NYHA III–IV functional class [patients, n (%)] | 25 (67.6) | 22 (59.5) | 3.63 | 0.58 |
| Ejection fraction (mean ± SD) | 52.6 ± 9.7 | 50.6 ± 7.8 | −9.8 | 0.5 |
| Extracardiac vasculopathy [patients, n (%)] | 11 (29.7) | 9 (24.3) | −9.9 | 0.79 |
| Previous cardiac surgery [patients, n (%)] | 3 (8.1) | 3 (8.1) | 0 | 1 |
| Serum creatinine (mg/dl ± SD) | 1.1 ± 0.5 | 1.2 ± 0.9 | 3.05 | 0.87 |
| Pulmonary hypertension [patients, n (%)] | 10 (27) | 9 (24.3) | −5.01 | 0.3 |
| Logistic EuroSCORE | ||||
| Median, IQR | 14.2 (7.3–19.7) | 14 (11.1–21.5) | −8.72 | <0.0001 |
| Mean ± SD | 16.1 ± 11 | 15.7 ± 8.5 | ||
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; IQR: interquartile range; SD: standard deviation; d: standardized differences; TAVI: transcatheter aortic valve implantation; RT: right anterior minithoracomy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
